Gou Qian, Gong Xin, Jin Jianhua, Shi Juanjuan, Hou Yongzhong
Department of Oncology, Affiliated Wujin People's Hospital, Jiangsu University, Changzhou, 212017, PR China.
Institute of Life Sciences, Jiangsu University, Zhenjiang, 212013, PR China.
Oncotarget. 2017 Jul 27;8(36):60704-60709. doi: 10.18632/oncotarget.19610. eCollection 2017 Sep 1.
Peroxisome-proliferator-activated receptors (PPARs) are nuclear hormone receptors including PPARα, PPARδ and PPARγ, which play an important role in regulating cancer cell proliferation, survival, apoptosis, and tumor growth. Activation of PPARs by endogenous or synthetic compounds regulates tumor progression in various tissues. Although each PPAR isotype suppresses or promotes tumor development depending on the specific tissues or ligands, the mechanism is still unclear. In this review, we summarized the regulative mechanism of PPARs on cancer progression.
过氧化物酶体增殖物激活受体(PPARs)是核激素受体,包括PPARα、PPARδ和PPARγ,它们在调节癌细胞增殖、存活、凋亡和肿瘤生长中发挥重要作用。内源性或合成化合物激活PPARs可调节各种组织中的肿瘤进展。尽管每种PPAR亚型根据特定组织或配体抑制或促进肿瘤发展,但其机制仍不清楚。在本综述中,我们总结了PPARs对癌症进展的调节机制。